INTRODUCTION
============

The cellular plasma membrane is a heterogeneous structure composed of various types of lipids and proteins, and this heterogeneity plays crucial roles in cellular signaling ([@B71]; [@B69]). The underlying physicochemical principles have been extensively studied ([@B42]; [@B69]). A first comprehensive concept to describe the membrane structure and dynamics was the fluid mosaic model of [@B73], which suggested a homogeneous multicomponent system in which, in the long range, processes are based on free Brownian motion, yet, in the short range, interactions of lipids and proteins can form small-scale heterogeneous complexes. Later models suggested a more elaborate suborganization of the membrane into functional domains ([@B72]). These nanodomains, referred to as membrane rafts, were proposed to be enriched in cholesterol and saturated lipids ([@B72]) and be highly dynamic ([@B49]; [@B66]). Besides the relatively general raft concept, nanoclusters of specific membrane components have been reported. Glycophosphatidylinositol-anchored proteins (GPI-APs; [@B78]), ganglioside GM1 ([@B86]), sphingomyelin ([@B24]), and specific immune receptor clusters ([@B14]) are examples shown to build up nanoscale heterogeneous structures in the plasma membrane ([@B59]).

Although the existence of rafts as a general organizing concept of the plasma membrane is under debate ([@B33]; [@B65], [@B69]), there is a consensus on the presence of membrane heterogeneity in terms of structure and dynamics ([@B66]). The temporal heterogeneity, for instance, is often quantitatively investigated by measuring diffusion of proteins and lipids in the cellular plasma membrane. Such diffusion measurements were used to determine the molecular mobility in segregated domains ([@B31]; [@B70]), elucidate the binding dynamics of cell surface receptors ([@B85]), and investigate the influence of the underlying cytoskeleton structure on membrane dynamics ([@B39], [@B40]; [@B47]; [@B2]; [@B21]; [@B37]; [@B36]) and the formation of transient interactions ([@B16]; [@B29]), to name just some applications.

An important tool to measure molecular mobility in membranes is fluorescence correlation spectroscopy (FCS; [@B18]; [@B61]). In FCS, an apparent diffusion coefficient, *D*, is determined from the average transit time of fluorescently tagged molecules moving into and out of a microscope's observation spot. FCS data recorded for different observation spot sizes demonstrated that different components of the plasma membrane diffuse not only with different velocities but also with different diffusion modes ([@B82]; [@B16]). The diffusion mode defines how the apparent diffusion coefficient of molecules changes with the size of the observation spot ([@B15]). [Figure 1](#F1){ref-type="fig"} illustrates proposed diffusion modes and their possible underlying mechanisms. For a molecule undergoing free (Brownian) diffusion, the apparent diffusion coefficient is not dependent on the size of the observation spot ([Figure 1](#F1){ref-type="fig"}A). This is different for hindered diffusion; for example, *D* will decrease with decreasing observation spot size diameter, *d*, if molecules are transiently immobilized or trapped in, for example, immobile or slow-moving molecular complexes ([Figure 1](#F1){ref-type="fig"}B; [@B16]; [@B47]). On the other hand, *D* will increase toward smaller *d* when molecules undergo hop or compartmentalized diffusion ([Figure 1](#F1){ref-type="fig"}C; [@B20]; [@B9]; [@B2]). In case molecules are transiently incorporated into domains where their diffusion is slowed, *D* will decrease toward smaller *d* in a similar manner as for trapped diffusion but will level out or slightly increase again as *d* gets closer to the diameter of the domain size ([Figure 1](#F1){ref-type="fig"}D; [@B28]; [@B25]; [@B57]). As outlined, the *D*(*d*) dependence is usually determined by measuring FCS data for different observation sizes (spot-variation FCS; [@B26]). This can be done either on conventional confocal microscopes with diffraction-limited observation spots with *d* \> 200 nm ([@B82]) or on a superresolution stimulated emission depletion (STED) microscope with *d* \< 200 nm ([@B16]). The latter has the advantage of measuring the diffusion closer to the length scales of the features causing hindrances.

![Possible diffusion modes in the cellular plasma membrane revealed by (left) determination of the apparent diffusion coefficient (*D*, Diff. Coef.) for different values of observation spot diameter (*d*) and (right) the potential molecular mechanisms behind these diffusion modes (red, molecular diffusion track; green and blue, large confocal and small STED microscope observation spots, respectively; gray, lipids; black, actin cytoskeleton; purple, actin-anchored transmembrane proteins). (A) Free diffusion; *D* remains constant. (B) Trapped diffusion; *D* decreases with decreasing *d*, presumably due to transient binding to immobile or slow-moving interaction partners, possibly assisted by the actin cytoskeleton. (C) Hop diffusion; *D* increases toward small *d* due to compartmentalization of the membrane by the cortical actin meshwork and transmembrane proteins associated with it, leading to fast diffusion inside the compartments as probed at small *d* and hindrance in crossing from one to the next compartment as observed at large *d*. (D) Transient domain incorporation; *D* decreases toward smaller *d* in a similar manner as in the trapping diffusion but levels out or slightly increases as the spot size gets closer to the domain size because diffusion is slowed down inside the domains, due, for example, to an increased molecular order.](1507fig1){#F1}

The diffusion mode of membrane molecules is a powerful indicator of their interaction dynamics and their bioactivity. Specifically, lipids may serve as signaling modulators for proteins with which they interact. For example, various membrane proteins have specific binding motifs for cholesterol ([@B60]), gangliosides ([@B12]), or sphingomyelin ([@B11]), which are crucial for the functionality of these proteins. Further, lateral diffusion of an active interferon-γ receptor is modulated by sphingomyelin and cholesterol, whereas that of an inactive mutant of this receptor is confined by the actin cytoskeleton ([@B5]). In addition, molecular simulations have shown a strong dependence of the conformation of proteins on the surrounding lipid membrane's dynamics ([@B51]). Therefore exact determination of the diffusion modes of lipids and elucidation of their underlying regulatory principles offer crucial insights into the organization and functionality of membrane lipids and proteins. Unfortunately, the exact mechanisms causing the diffusion modes of lipids and proteins could not be unequivocally resolved. For example, trapped diffusion is believed to be caused by transient interactions with extremely slow or immobile membrane components (their exact identity being undiscovered) and to be assisted by cholesterol and the actin cytoskeleton ([Figure 1](#F1){ref-type="fig"}B; [@B16]; [@B47]). Hop diffusion is proposed to be induced by confinement from the cortical actin cytoskeleton meshwork and transmembrane proteins associated with it ([Figure 1](#F1){ref-type="fig"}C; [@B55]; [@B40]; [@B2]). The domains into which molecules could transiently incorporate may follow the lipid raft idea ([@B82]). Many of these proposals were obtained from experiments using cell-perturbing drugs, such as cholesterol-oxidizing drugs or those depolymerizing the actin cytoskeleton. Yet the action of these drugs might be manifold. Therefore experiments under more-controlled conditions and in minimal systems containing only the essential elements are necessary to confirm the molecular mechanisms inducing the different hindrances in diffusion.

In this study, we use STED-FCS to compare the diffusion modes of fluorescently labeled lipids and GPI-anchored proteins (GPI-AP) in the plasma membrane of live cells and cell-derived membrane vesicles, so-called giant plasma membrane vesicles (GPMVs). Despite having their own artifacts caused by chemical vesiculation, GPMVs display an excellent model of the cellular membrane ([@B62]) because they contain most of the natural membrane components but lack the actin cytoskeleton ([@B4]). Our data underline the crucial role of the actin cortex in maintaining hindered diffusion modes of most but not all membrane molecules because hindered diffusion is to a large extent abolished in actin-free GPMVs. The use of STED-FCS on GPMVs constitutes a powerful experimental approach to investigate nanoscale lipid and protein dynamics in an isolated plasma membrane environment.

RESULTS
=======

Measurements in cells and GPMVs
-------------------------------

All of our measurements were performed on live adherent PtK2 or CHO cells and on GPMVs generated therefrom. The generation of GPMVs was induced using paraformaldehyde (PFA)/dithiothreitol (DTT) following a well-established protocol ([@B67]). To exclude PFA/DTT-specific artifacts, we also tested GPMVs formed using *N*-ethylmaleimide (NEM), which gave similar results on diffusion of molecules (Supplemental Figure S1). SNAP- or fluorescently-tagged GPI-APs were expressed in the cells before GPMV formation. Fluorescently tagged lipids were incorporated into the GPMV membrane at relatively low concentrations after formation. One artifact that could potentially cause inaccuracies in diffusion measurements is the presence of molecules stuck to the glass coverslip. To eliminate this possibility and confirm proper plasma membrane incorporation of the fluorescent lipid analogues, we trypsinized the cells after treatment with lipid analogues as described previously ([@B6]). The time-lapse images confirmed that the signal originated from the cell membrane but not from molecules bound to the coverslip or to the cell surface proteins (Supplemental Figure S2). Measurements were carried out at room temperature, which minimized internalization of the fluorescent molecules and thus background signal ([@B16]). We measured cells for not longer than 45 min at room temperature, during which the cells remained healthy. Moreover, representative results from diffusion mode measurements obtained at 37°C were similar to those obtained at room temperature (Supplemental Figure S3). We also carefully investigated the miscibility transition temperature of GPMVs to avoid artifacts resulting from phase separation at room temperature (Supplemental Figure S4). Finally, GPMVs were still mobile, making some of the measurements, especially the acquisition of 10- to 30-s FCS data, challenging. Hence we immobilized GPMVs by incorporating a small amount of lipids with a biotinylated PEG linker into the membrane of GPMVs and depositing them on a streptavidin-functionalized microscope coverglass surface ([Figure 2](#F2){ref-type="fig"}A). We confirmed that immobilization did not influence the molecular diffusion in the membrane of the GPMVs by comparing FCS data obtained at the basal and apical membrane of immobilized GPMVs and of rarely appearing, nonmoving, nonimmobilized GPMVs (Supplemental Figure S5). In the following, we determine molecular diffusion at the basal membrane of the immobilized GPMVs because it yielded the most reproducible measurements due to the high--numerical aperture (NA) oil objective we applied for STED-FCS experiments.

![Distribution of actin and diffusion of lipids and GPI-AP in cells and GPMVs. (A) Immobilization strategy for GPMVs. (B) Confocal images of the equatorial plane of adherent CHO cells (top) expressing Lifeact-GFP (green) and GPMVs derived therefrom (bottom). The plasma membrane is visualized with CellMask Deep Red (red). In the cells, the actin cortex is clearly visible (yellow). Scale bar, 10 µm. (C) Representative FCS data of the actin marker Lifeact-GFP in the equatorial plane (cytoplasm; top) and the basal membrane (actin cortex; bottom) of live CHO cells. The bottom plot shows two components (C1, actin cortex; C2, cytoplasmic). (D) Transit times of cytoplasmic GFP (cyt-GFP) and Lifeact-GFP (LA-GFP) in CHO cells and GPMVs at equatorial or basal plane, as determined by FCS. The absence of a slow component in the GPMVs confirms the absence of an intact actin cortex. (E) Diffusion coefficients obtained by confocal FCS recordings of Atto647N-DOPE, TopFluor-cholesterol (TF-Chol), Atto647N-GM1, and GPI-AP (labeled via a SNAP tag) in live CHO cells (green), GPMVs (red), and GUVs (blue). Error bars are SDs of the mean of at least 10 measurements on different cells or vesicles. Spot size was ∼200 nm for TF-Chol (485-nm excitation) and ∼240 nm for the others (640-nm excitation). Statistical significance was evaluated by unpaired *t* test.](1507fig2){#F2}

GPMVs lack organized cytoskeleton
---------------------------------

We first probed the organization of actin in the GPMVs to confirm the lack of actin cytoskeleton in these vesicles. We visualized the actin organization in adherent and suspended cells and in GPMVs derived therefrom. [Figure 2](#F2){ref-type="fig"}B shows the filamentous actin (F-actin) organization in live adherent CHO cells expressing Lifeact--green fluorescent protein (Lifeact-GFP; a versatile fluorescence marker that transiently binds F-actin in living cells), where the cortical actin cytoskeleton is clearly visible as a bright structure beneath the plasma membrane ([@B7]). In contrast, in the CHO cell--derived GPMVs, we observed no such cortical actin network underneath the membrane; instead, actin was homogeneously distributed inside the GPMVs ([Figure 2](#F2){ref-type="fig"}B). Similarly, monomeric actin (or globular actin \[G-actin\], labeled with the fluorescent protein citrine) localized primarily to the cell cortex, whereas it was homogeneously distributed inside the GPMVs (Supplemental Figure S6A). To unambiguously exclude the formation of a membrane-associated assembled cortical actin cytoskeleton in the GPMVs, we performed confocal FCS measurements for Lifeact-GFP in the cytosol (distant from the membrane, in the equatorial plane) and within the cortical actin cytoskeleton (at the plasma membrane, in the basal plane) of living CHO cells. The average transit times of Lifeact-GFP through the observation spot differed for cells and GPMVs. In cells, diffusion was equally fast in the cytosol as well as for one of the components at the basal plane, whereas another component at the basal plane exhibited a significantly reduced mobility, as expected within the intact cortex, where Lifeact-GFP transiently binds F-actin ([Figure 2](#F2){ref-type="fig"}, C and D). Control experiments with free cytoplasmic GFP (cyt-GFP) confirmed that the first component resembles the free cytosolic Lifeact-GFP ([Figure 2](#F2){ref-type="fig"}D). In GPMVs, mobility was equally fast for cyt-GFP and Lifeact-GFP in the equatorial plane and in the basal membrane. Disappearance of the slow component (component C1 in [Figure 2](#F2){ref-type="fig"}C) in GPMVs indicates that only purely free Lifeact-GFP is present in the vesicles. It is worth noting that the cytosolic diffusion was relatively faster in GPMVs than in live cells, presumably due to the absence of organelles and cytoskeletal elements (e.g., microtubules), which causes a less crowded environment within the GPMVs. Finally, we treated GPMVs with the F-actin--depolymerizing drug latrunculin B, which would disrupt any remaining cortical actin structures; yet we observed no significant differences in lipid mobility between latrunculin-treated and untreated GPMVs (Supplemental Figure S6B). In conclusion, we confirmed that the cortical actin cytoskeleton was abolished in GPMVs.

Mobility of lipids in cells, GPMVs, and GUVs
--------------------------------------------

Cortical actin has tremendous effect on the membrane structure and dynamics, which are usually elucidated using actin-targeting drugs ([@B40]; [@B47]; [@B37]; [@B36]; [@B58]). To understand the effect of complete absence of the actin cortex on molecular diffusion in membranes, we tested the mobility of fluorescent (Atto647N- or TopFluor-labeled) analogues of an unsaturated phospholipid (Atto647N--1,2-dioleoyl-*sn*-glycero-3-phosphoethanolamine \[DOPE\]), cholesterol (TF-Chol), and the glycolipid GM1 (Atto647N-GM1) in the plasma membrane of live CHO cells, in GPMVs derived therefrom, and in artificial free-standing giant unilamellar vesicles (GUVs; 100% 1,2-dioleoyl-*sn*-glycero-3-phosphocholine \[DOPC\]). We applied confocal FCS to determine average diffusion coefficients of these analogues.

Diffusion of all tested lipid analogues was significantly faster in GPMVs than in living cells but still significantly slower than in the GUVs ([Figure 2](#F2){ref-type="fig"}E). The difference in diffusion between cells and GPMVs is presumably due to the lack of the actin cortex in GPMVs; hindrance due to the actin-mediated compartmentalization ([@B21]) is likely to be abolished in GPMVs. The difference between the GUVs and GPMVs can be attributed to less molecular crowding in GUVs due to the absence of proteins ([@B30]). All tested molecules diffused with similar diffusion coefficients in GUVs (*D* ≈ 8.5 µm^2^/s). In live cells, Atto647N-DOPE and Atto647N-GM1 had similar diffusion coefficients (*D* ≈ 0.5 µm^2^/s), whereas TF-Chol was notably faster (*D* ≈ 1.2 µm^2^/s, in accordance with previous findings ([@B74]; [@B27]). Yet, in GPMVs, Atto647N-DOPE and TF-Chol had similar diffusion coefficients (*D* ≈ 2.5 µm^2^/s). The larger increase in mobility from live cells to GPMVs for Atto647N-DOPE compared with TF-Chol suggests a stronger confinement of the phospholipid analogue by the cortical actin cytoskeleton than of cholesterol. In comparison, diffusion of Atto647N-GM1 increased only threefold from *D* ≈ 0.5 µm^2^/s in live cells to *D* ≈ 1.5 µm^2^/s in GPMVs, which highlights that hindrances in diffusion of the GM1 analogue seems to be less associated with the actin cortex.

Hindered diffusion in cells and GPMVs
-------------------------------------

Hindered diffusion in the plasma membrane of intact living cells has been reported several times for lipid analogues---specifically, trapped diffusion in the case of sphingomyelin or GM1 ([@B16]; [@B47]; [@B68]) and hop diffusion in the case of phospholipids such as DOPE ([@B20]; [@B9]; [@B2]). We investigated whether these hindered diffusion modes are present also in GPMVs. Using STED-FCS, we tested the diffusion modes of four different lipid analogues, all labeled with the organic dye Atto647N: a saturated (Atto647N--1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine \[DPPE\]) and an unsaturated (Atto647N-DOPE) phospholipid, as well as sphingomyelin (Atto647N-SM) and the ganglioside GM1 (Atto647N-GM1). As outlined in [Figure 1](#F1){ref-type="fig"}, STED-FCS measurements allow us to determine the dependence of the apparent diffusion coefficient, *D*, on the diameter of the microscope's observation spot, *d*, elucidating the nanoscale diffusion mode.

In cells, Atto647N-DPPE diffused freely ([Figure 3](#F3){ref-type="fig"}, A and B, as expected for PtK2 cells; [@B16]), whereas we found two pools (P1 and P2) of differently diffusing Atto647N-DOPE lipid ([Figure 3](#F3){ref-type="fig"}, C and D). Varying between individual cells or even different positions on the same cell, we found either characteristics of free diffusion (P2, ∼60% of the cases) or slight hop diffusion (P1, ∼40% of the cases), which underlines the large heterogeneity in the cellular membrane organization. Atto647N-SM showed trapped-like diffusion in cells ([Figure 3](#F3){ref-type="fig"}, E and F), as shown previously for PtK2 cells ([@B16]).

![Diffusion modes of Atto647N-labeled lipid analogues in live cells (green) and GPMVs (red) revealed by STED-FCS. (A, C, E, G) Dependences of the apparent diffusion coefficient (*D*, Diff. Coef.) on the observation diameter (*d*) and (B, D, F, H) ratio *D*~STED~/*D*~Conf~ calculated from these *D*(*d*) dependences (*D*~STED~ and *D*~Conf~; diffusion coefficients at ∼50- and 240-nm observation diameter, respectively) for (A, B) Atto647N-DPPE, (C, D) Atto647N-DOPE showing two different pools, P1 and P2, (E, F) Atto647N-SM, and (G, H) Atto647N-GM1. Error bars are SDs of the mean of at least 10 individual measurements on different cells or vesicles. *D*~Conf~ is the rightmost value in the graphs (STED laser power = 0), and *D*~STED~ is the leftmost (STED power ≈ 200 mW). (I) Monte Carlo simulations of free (red), hop (blue), and trapped (green) diffusion, yielding the shown *D*(*d*) dependences, as detailed in *Materials and Methods*. (J) Monte Carlo simulation of transient incorporation into 20-nm nanodomains. The resulting *D*(*d*) dependence indicates a kink well above the domain size.](1507fig3){#F3}

In GPMVs, diffusion of the DOPE, DPPE, and SM analogues turned free with approximately fivefold-increased mobility ([Figure 3](#F3){ref-type="fig"}, A, C, and E). The abolition of hindered diffusion in GPMVs is further highlighted by plotting the ratio *D*~STED~/*D*~Conf~ of the apparent diffusion coefficients. *D*~STED~ and *D*~Conf~ were determined from the FCS recordings with maximum and zero STED laser power, respectively ([Figure 3](#F3){ref-type="fig"}A, black boxes). *D*~STED~/*D*~Conf~ = 1 indicates free, *D*~STED~/*D*~Conf~ \> 1 hop, and *D*~STED~/*D*~Conf~ \< 1 trapped diffusion. In cells, we found *D*~STED~/*D*~Conf~ ≈ 1 for Atto647N-DPPE ([Figure 3](#F3){ref-type="fig"}B), as well as for one pool of Atto647N-DOPE (P2; [Figure 3](#F3){ref-type="fig"}D), *D*~STED~/*D*~Conf~ ≈ 1.8 for the other pool of Atto647N-DOPE (P1; [Figure 3](#F3){ref-type="fig"}D), and *D*~STED~/*D*~Conf~ ≈ 0.38 for Atto647N-SM ([Figure 3](#F3){ref-type="fig"}F). In contrast, *D*~STED~/*D*~Conf~ values close to ∼1 were found for all of these probes (except GM1, which will be discussed soon) in GPMVs, confirming their free diffusion in GPMV membrane. Diffusion of the lipid analogues in CHO cells confirmed that the observed diffusion modes were not specific to PtK2 cells (Supplemental Figure S7).

Actin-(in)dependent, transient nanodomain incorporation of GM1
--------------------------------------------------------------

In the case of Atto647N-GM1, we observed trapped-like diffusion in both live cells and GPMVs (*D*~STED~/*D*~Conf~ ≈ 0.55 in live cells and 0.83 in GPMVs; [Figure 3](#F3){ref-type="fig"}, G and H) with approximately threefold difference in overall mobility, which was much lower than the approximately fivefold difference observed for the other lipid analogues. Therefore STED-FCS measurements confirmed the confocal FCS data (compare [Figure 2](#F2){ref-type="fig"}E); hindered diffusion of GM1 is influenced by the actin cytoskeleton to a much smaller extent than that of sphingomyelin.

A closer look at the *D*(*d*) dependence of Atto647N-GM1 in [Figure 3](#F3){ref-type="fig"}G suggests that this lipid analogue may be transiently incorporated into nanodomains in both cells and GPMVs, unlike pure trapped diffusion observed for Atto647N-SM (compare also [Figure 1](#F1){ref-type="fig"}, B and D). As mentioned, in purely trapped diffusion, a molecule is not moving during the transient halt, whereas during domain incorporation, the "trapped" molecule is still diffusing with relatively slower velocity, causing a kink in the *D*(*d*) plot ([Figures 1](#F1){ref-type="fig"}D and [3](#F3){ref-type="fig"}G). This deviation from the linear decrease is small yet significant. Such transient domain incorporation of GM1 in artificial vesicles was previously suggested ([@B43]; [@B1]).

Simulations of diffusion modes
------------------------------

To confirm and better understand the observed phenomena, we carried out Monte Carlo simulations of different diffusion modes, namely free, hop, and trapped diffusion, as well as transient domain incorporation, and generated respective *D*(*d*) dependences (see *Materials and Methods* for details). Obtained *D*(*d*) dependences ([Figure 3](#F3){ref-type="fig"}, I and J) were in accordance with those expected from theory (compare [Figure 1](#F1){ref-type="fig"}) and with the experimental results. The *D*~STED~/*D*~Conf~ ratios from the simulated *D*(*d*) dependences (with *d* = 40 nm for STED and 250 nm for confocal images) were comparable with those extracted from the experimental data (e.g., *D*~STED~/*D*~Conf~ ≈ 1 for free diffusion for Atto647N-DPPE; *D*~STED~/*D*~Conf~ ≈ 0.3 for trapped diffusion vs. ∼0.3--0.4 for Atto647N-SM and ∼1.3--1.8 for hop diffusion for Atto647N-DOPE). In addition, the general tendency of *D*(*d*) dependence for transient incorporation into nanodomains as observed for GM1 was confirmed with simulations ([Figure 3](#F3){ref-type="fig"}J). It is worth noting that the kink in the *D*(*d*) plot appears at much larger observation spot diameters than the actual domain size.

Of course, the exact shape and positioning of the simulated *D*(*d*) dependences depend on various parameters, such as diffusion coefficient of free movement between traps or within compartments, compartment sizes, hopping/trapping probabilities and times, and nanodomain sizes and inner-domain diffusion properties ([@B82]; [@B56]; [@B57]). Such parameters vary drastically from one cell to another, as well as within an individual cell ([@B79]). A particular challenge for simulating the domain diffusion is the mobility of the domain itself ([@B57]). Moreover, individual molecules might go through different diffusion modes, such as trapped and hop diffusion simultaneously. Because this scenario may cause a kink as well if the incline (hop diffusion) and decline (trapped diffusion) in the *D*(*d*) plot cancel each other, we simulated this situation. We found that trapped diffusion usually dominates the *D*(*d*) dependence, with hop diffusion only leading to a general shift toward smaller values of *D* (Supplemental Figure S8). Consequently the most likely diffusion mode in the case of the GM1 analogue for both live cells and GPMVs is transient incorporation into relatively slowly moving nanodomains. Related to this, note that such GM1-containing nanodomains in GPMVs were apparent at 37°C and also in GPMVs prepared using NEM instead of PFA/DTT (Supplemental Figure S3).

Diffusion and organization of GPI-APs in cells and GPMVs
--------------------------------------------------------

GPI-APs play important roles in multiple cellular processes, but their organization in the cell membrane is controversial ([@B64]). Thus we next investigated the diffusion and organization of GPI-APs in live cells and GPMVs. We expressed GPI-anchored SNAP-tag domains (GPI-SNAPs) in PtK2 and CHO cells and labeled them with the functionalized dye Abberior Star Red. STED microscopy images of the spatial organization of the GPI-APs in the live cells revealed ∼100-nm large, bright, and sparse clusters (Supplemental Figure S9A), which disappeared in the GPMVs. Further, confocal FCS data taken for GPI-SNAPs exhibited a much slower approximately fivefold) diffusion in the live cells (*D* ≈ 0.5 µm^2^/s) compared with the GPMVs (*D* ≈ 2.5 µm^2^/s), similar to the Atto647N-DOPE lipid ([Figure 2](#F2){ref-type="fig"}E). Finally, STED-FCS on GPI-SNAPs ([Figure 4](#F4){ref-type="fig"}A) indicated trapped-like diffusion in live cells (*D*~STED~/*D*~Conf~ ≈ 0.5), which was abolished in GPMVs (*D*~STED~/*D*~Conf~ ≈ 1; [Figure 4](#F4){ref-type="fig"}, A and B). For STED-FCS measurements of GPI-APs on GPMVs, we had to use a slightly modified labeling strategy because the GPI-SNAPs could not be labeled efficiently enough, yielding too low signal for the STED-FCS recordings. We therefore used red fluorescent protein (RFP)--tagged GPI-APs (GPI-RFP), whose fluorescence signal was further amplified using an Atto647N-labeled nanobody against RFP.

![Diffusion of GPI-AP in cells and GPMVs. (A) Dependence of the apparent diffusion coefficient (*D*, Diff. Coef.) on the observation spot diameter (*d*) for GPI-SNAP in PtK2 cells (green, showing deviation from pure trapped diffusion, which is supposed to overlap with the dashed black line) and GPI-RFP labeled with a Atto647N-tagged nanobody in GPMVs (red), and (B) corresponding ratio *D*~STED~/*D*~Conf~ (with *D*~STED~ and *D*~Conf~ values of *D* at ∼50 and 240 nm, respectively). Error bars are SDs of the mean of at least 10 measurements on different cells or vesicles. (C) Confocal images of cells expressing GPI-anchored Lypd6 proteins labeled with GFP (green; top) and RFP (red; bottom), showing overlapping bright clusters (Pearson *r* = 0.51 ± 0.1). Scale bar, 10 µm. (D, E) Fluorescence signal over time from the Lypd6 clusters for the GFP (green) and RFP (red) label. (D) Line scans (space, *x*-axis) vs. time (*y*-axis from top to bottom) with a bright signal spot fading over time, and (E) corresponding fluorescence intensity vs. time. (F) Autocorrelation (FCS; red and green) and cross-correlation (FCCS; blue) functions of Lypd6-GFP and Lypd6-RFP in the plasma membrane of live PtK2 cells, together with a fit to the data (black), showing high mobility of both Lypd6-GFP and Lypd6-RFP (FCS data) but no codiffusion (FCCS data). For FCCS controls, see Supplemental Figure S12.](1507fig4){#F4}

To exclude an influence by the SNAP-labeling strategy or by the choice of GPI-AP type, we also explored the dynamics and organization of Lypd6. Lypd6 is a crucial GPI-AP involved in Wnt/β-catenin signaling ([@B48]). We expressed RFP-tagged Lypd6 proteins in PtK2 and CHO cells (Lypd6-RFP) and again further amplified their signal with an Atto647N-labeled nanobody against RFP. Lypd6-RFP also formed ∼100-nm large, bright, and sparse clusters (Supplemental Figure S9B) that were not visible in GPMVs (Supplemental Figure S10A) and revealed hindered, trapped-like diffusion in live cells but not in GPMVs (*D*~STED~/*D*~Conf~ ≈ 0.4--0.5 in live cells and ≈ 1 for GPMVs; Supplemental Figure S9C); similar to GPI-SNAP. We excluded possible artifacts due to unspecific binding of the nanobody to the coverslip surface, since we observed efficient and specific labeling of Lypd6-RFP on the membrane surface (Supplemental Figure S9D).

We sought to characterize further the ∼100-nm large, bright, and sparse clusters of the GPI-APs in live cells. First, we expressed GFP- and RFP-tagged Lypd6 (Lypd6-GFP and -RFP) proteins in PtK2 and CHO cells. Two-color confocal images confirmed the existence of bright and sparse clusters accommodating both Lypd6-GFP and Lypd6-RFP ([Figure 4](#F4){ref-type="fig"}C; significant spatial overlap of GFP and RFP signals, Pearson *r* = 0.51 ± 0.1). GFP- or RFP-tagged Lypd6 showed no visible signs of such bright and sparse clusters in GPMVs (Supplemental Figure S10A). Further, the clusters were immobile or extremely slowly moving (Supplemental Movie S1). Repetitive scanning over the visible clusters showed quickly fading fluorescence signals for both GFP and RFP ([Figure 4](#F4){ref-type="fig"}, D and E), which shows that there was no fast interchange or replenishment of GPI-APs within these clusters. Finally, we confirmed that the clusters were plasma membrane entities and not endocytic vesicles by costaining with membrane- and endocytosis-specific markers (Supplemental Figure S11).

The static properties of these bright and sparse clusters revealed that they were not involved in the diffusion dynamics of the GPI-APs that we observed by the confocal and STED-FCS experiments. Consequently there must be two pools of GPI-APs in the live cells---one mobile pool and one organized in rather static clusters. Yet our STED-FCS measurements revealed that the diffusion of the mobile pool was still hindered. A close inspection of the *D*(*d*) dependence of [Figure 4](#F4){ref-type="fig"}A even indicates transient incorporation into nanodomains as for GM1 but with a dependence on the cortical actin, as this hindrance disappears in GPMVs. Comparison with our Monte Carlo simulations ([Figure 3](#F3){ref-type="fig"}J) suggests that these nanodomains must be \<20 nm in diameter. We further studied transient trapping or nanodomain incorporation by fluorescence cross-correlation spectroscopy (FCCS) of Lypd6-GFP and Lypd6-RFP. We expected a nonzero FCCS curve amplitude in case of a significant codiffusion of GPI-APs, which would be the case for incorporation into stable and mobile nanodomains accommodating more than one GPI-AP. However, we observed near-zero amplitude in the FCCS curves between different Lypd-GFP and Lypd-RFP ([Figure 4](#F4){ref-type="fig"}F). We confirmed this using GPI-SNAP tagged with differently colored fluorophores, as well as GPI-GFP and GPI-RFP (Supplemental Figure S12). To validate the FCCS approach, we used control samples to test the alignment of our system, which could successfully identify codiffusing molecules (Supplemental Figure S12). It is worth noting that FCCS, due to noise issues, is probably not capable of revealing the codiffusion of a fairly small fraction (\<5%) of codiffusing molecules ([@B32]).

In conclusion, we identified two pools of GPI-APs in live cells---one organized in ∼100-nm large, bright, sparse, and static clusters and another, highly mobile pool that transiently incorporates into \<20-nm nanodomains. Both the static clusters and dynamic nanodomains were not detectable in the GPMVs, highlighting that both features were associated with the actin cytoskeleton. Note that the GPI-APs generally tend to partition into more ordered lipid environments (as probed in phase-separated GPMVs; Supplemental Figure S10B), highlighting that the clusters and/or nanodomains might be of high molecular order, thus exhibiting slower diffusion.

DISCUSSION
==========

Using STED-FCS, we compared the diffusion modes of several fluorescent lipid analogues and GPI-APs in the plasma membrane of live cells and cell-derived GPMVs. In all cases, diffusion was much faster in GPMVs, and hindrances in diffusion were weakened or mostly abolished. Fluorescence imaging and FCS measurements of the cortical actin in cells compared with GPMVs demonstrated the absence of this network in GPMVs, suggesting the essential role of the actin cortex in maintaining hindered diffusion modes in living cells. Specifically, fluorescent DPPE, DOPE, and SM lipid analogues showed free, hop, and trapped diffusion in live PtK2 and CHO cells, respectively, and they all exhibited free diffusion with approximately fivefold increased diffusion coefficients in GPMVs. In contrast, the hindered diffusion of a fluorescent GM1 analogue in live cells was not completely abolished in GPMVs, with only a threefold increase in overall mobility. The STED-FCS data, supported by Monte Carlo simulations, suggested transient incorporation into nanodomains in both live cells and GPMVs. It seems that the actin cortex has much less influence on the diffusion dynamics of GM1 than, for example, of SM, confirming previous STED-FCS measurements using actin-perturbing drugs ([@B47]). The distinct diffusion characteristics of the GM1 might be crucial for its specific role in membrane bioactivity. GM1 is one of the most ubiquitous glycolipids of the cell membrane and is essential in host--pathogen interactions ([@B3]). Further, GM1 forms functional homodomains ([@B1]) or heterodomains with GPI-APs ([@B35]).

For GPI-APs, we identified two pools in live cells---one organized in ∼100-nm large, bright, sparse, and very static clusters, and another, highly mobile pool that transiently incorporates into nanodomains. Both the static clusters and dynamic nanodomains are not detectable in the GPMVs, suggesting that both features are associated with the actin cytoskeleton and that these nanodomains have a different nature than GM1 domains. The static clusters are most probably those highlighted in previous studies ([@B52]) and are completely separate from the mobile pool, in which we found no sign of codiffusing GPI-APs.

Our data confirm that hop diffusion can be explained by compartmentalization of the plasma membrane due to the underlying actin cytoskeleton ([@B20]; [@B2]). Moreover, the trapping of sphingomyelin is associated with the actin cytoskeleton, most probably due to interactions with molecules whose mobility is modulated by the actin cortex ([@B47]). However, in contrast to previous drug treatments ([@B47]; [@B2]), which may affect many other cellular features besides the actin cytoskeleton, here we investigated these dependences without the use of such drugs but instead on cell-derived plasma membranes. Although other factors, such as nonequilibrium processes (e.g., endocytosis and exocytosis) or membrane leaflet asymmetry are also believed to be absent in GPMVs ([@B67]), the absence of an intact actin cortex is the most prominent factor for influencing molecular membrane diffusion. Furthermore, the consensus of the differently designed experiments (drug treatments vs. GPMVs, or single-particle tracking vs. STED-FCS) manifests the strong role of the actin cytoskeleton in molecular membrane diffusion. Similarly, the strong dependence of the formation of sparse and static GPI-AP clusters on the actin cytoskeleton is also in accordance with previous biochemical and microscopy data ([@B63]; [@B52]). Yet the simultaneous disclosure of another mobile pool of GPI-APs, which transiently incorporates into highly dynamic nanodomains, is novel, bringing a perspective to the possible controversies between the reported GPI-AP clusters and previous single-particle tracking studies ([@B83]; [@B50]). Finally, although mild actin dependence of GM1-hindered diffusion has been reported before ([@B47]), more detailed analysis performed here highlights that this hindrance is due to the transient incorporation into nanodomains. It is intriguing that these domains are maintained without the actin cytoskeleton and in a passive environment of GPMVs. In general, dual-color STED-FCCS will be required to further elucidate the diffusion modes, for example, by additionally labeling potential binding partners. A particularly interesting question is whether pronounced actin structures such as podosomes ([@B76]) or stars, asters, and vortices ([@B38]; [@B19]) serve as pinning sites for interaction partners.

Another intriguing question is why the STED-FCS recordings of only certain molecules such as DOPE but not all molecules show hop diffusion. A reason could be the interplay between hop and trapped diffusion. Whereas hop diffusion leads to an increase in values of the apparent diffusion coefficient *D* with decreasing diameter of the observation spot, trapped diffusion shows the opposite effect. Our simulations show that the *D*(*d*) dependence for a molecule undergoing both hop and trapped diffusion is usually dominated by the trapping, with the hopping leading only to a general shift toward smaller values of *D*. Most probably, all lipids encounter hop diffusion, yet trapping (or domain incorporation) is more pronounced for SM, GM1, and GPI-APs. Further, local variations in the actin organization or binding partners across the cell lead to different diffusion characteristics at different positions in the cells. This explains the presence of two distinct pools of diffusion for DOPE. Complementary methods such as high-speed single-particle tracking, camera-based FCS, or scanning STED-FCS, which can probe spatial heterogeneity in diffusion, will be able to resolve the remaining challenges while still requiring sufficient time resolution ([@B20]; [@B13]; [@B29]; [@B75]; [@B45]). More elaborate simulations of different diffusion modes may also give additional insight.

Lipid--lipid and lipid--protein interactions are believed to be important for plasma membrane organization and bioactivity ([@B69]). Lipids have preferential interactions with other lipids and proteins due to their structural differences. For instance, sphingosine-based lipids can form hydrogen bonds with cholesterol ([@B53]), which is believed to be the basis for membrane raft domain formation, and several membrane proteins with binding pockets for specific lipids have been found ([@B11]). These lipid--lipid or lipid--protein interactions obviously influence their diffusion characteristics, and thus understanding the principles behind heterogeneous diffusion modes will give important insight into cell membrane structure and dynamics and hence bioactivity. It is well accepted that lipid bulk properties influence the activity of signaling molecules ([@B84]). Further, it has been shown that specific lipid--protein interactions modulate the activity of receptors ([@B12]; [@B41]). For these reasons, the organization of lipid species (particularly lipid-driven nanodomains) is of great importance. In a recent report, sphingomyelin metabolism was found to influence the dynamics of integrin clusters, proving a specific involvement of lipid dynamics in protein function ([@B17]). In another example, GPI-AP nanoclusters were shown to influence integrin-dependent signaling ([@B77]). Besides lipid-driven reorganization, cytoskeletal rearrangement was found to be a crucial player in signaling events ([@B44]). Thus an experimental system as presented here in which the diffusion of lipids and proteins with or without actin can be reliably measured is extremely valuable. The reach of our system is not limited to lipids and GPI-APs but can also be helpful for investigating the dependence of membrane receptor dynamics (e.g., clustering) on the actin cytoskeleton. Moreover, our methodology provides a straightforward system to distinguish energy-dependent active mechanisms (such as endocytosis and exocytosis) from energy-independent passive mechanisms. The hindered diffusion of GM1 in GPMVs we observed is an excellent example of such a passive event and of great interest because it has been shown that GM1 nanodomains are crucial for β-amyloid oligomerization, which plays an important role in Alzheimer disease ([@B1]). Our study confirms that this nanodomain formation of GM1 is not significantly dependent on the actin cytoskeleton or energy but instead is a passive clustering driven by presumably preferential interaction of lipids. In contrast, GPI-AP domain formation is strongly dependent on these factors, as they disappear in GPMVs. In conclusion, STED-FCS in combination with GPMVs serves as a powerful tool to reveal important details of molecular membrane organization and dynamics, particularly the role of organized cortical actin cytoskeleton.

MATERIALS AND METHODS
=====================

Tissue culture
--------------

PtK2 cells were grown in DMEM (Sigma-Aldrich) supplemented with 15% fetal bovine serum (FBS; Sigma-Aldrich) and 1% [l]{.smallcaps}-glutamine (Sigma-Aldrich). CHO cells were cultured in DMEM/F12 (Lonza) supplemented with 10% FBS and 1% [l]{.smallcaps}-glutamine. Jurkat T-cells were grown in RPMI 1640 (Sigma-Aldrich) containing 10% FBS, 1% [l]{.smallcaps}-glutamine, and 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES). RBL cells were cultured in DMEM (Sigma-Aldrich) supplemented with 10% FBS and 1% [l]{.smallcaps}-glutamine. For GPMV production, the cells were grown on 30 mm Petri dishes, and for diffusion measurements in live cells, they were grown on 18- or 25-mm round coverslips (\#1.5). Usually, the cells reached a confluency of 50--70% before the measurement was performed.

Cell labeling
-------------

Cells were labeled in phenol red--free L15 medium (Sigma-Aldrich) at a lipid concentration of 1 μg/ml (Atto647N-DPPE, -SM, -DOPE) for 15 min at room temperature. After two washes with L15, measurements were performed immediately. The labeling with Atto647N-H-GM1 was performed in full medium (2 μg/ml) for 15 min at room temperature. Lipid analogues were not bovine serum albumin (BSA) coupled.

The lipid analogues Atto647N-DOPE, Atto647N-DPPE, and Atto647N-SM were purchased from Atto-Tec. Atto647N-GM1 (C18:1, C18:0) was synthesized by Guenter Schwartzmann (University of Bonn, Bonn, Germany; [@B16]). TF-Chol was purchased from Avanti Polar Lipids. Transfections for PtK2 cells were performed using Lipofectamine 3000 (Thermo Fisher), and transfections for CHO cells were performed using Turbofect (Thermo Fisher), according to the manufacturer's protocols. See [@B48] for Lypd6-GFP and Lypd-RFP. GPI-SNAP was a gift from the lab of Stefan Hell (Max Planck Institute for Biophysical Chemistry, Göttingen, Germany), VAMP7 was obtained from the Wolfson Imaging Centre (Oxford, United Kingdom), and GPI-GFP and GPI-RFP were obtained from the lab of Kai Simons (Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany).

Labeling of GPI-RFP or Lypd6-RFP was performed with an RFP-binding nanobody labeled with Atto647N (ChromoTek). The nanobody was diluted to 100 μg/ml in 4% BSA in phosphate-buffered saline (PBS) and stored at 4°C. Labeling was performed at a final concentration of 1 μg/ml.

SNAP labeling with Abberior Star Red (Abberior) was performed at 2 μg/ml in full medium at 37°C for 30 min. After two washing steps with full medium at 37°C (30 min each), STED-FCS measurements and imaging were performed in L15.

Cell-mask labeling was done by adding 0.5 µM (final concentration) CellMask Deep Red (Thermo Fisher) in full medium. It was incubated for 15 min at room temperature and washed twice with L15 afterward.

GPMVs
-----

Cell-derived GPMVs were prepared according to [@B67]. Briefly, cells were grown to a confluency of ∼70%, washed with GPMV buffer (containing 10 mM HEPES, 150 mM NaCl, 2 mM CaCl~2~, pH 7.4), and after adding 2 mM DTT and 25 mM PFA, the cells were incubated for at least 4 h (PtK2 cells) or 2 h (CHO/RBL cells) at 37°C to allow the cells to produce a sufficient amount of GPMVs. In the case of the vesiculation agent NEM, the cells were washed with GPMV buffer and incubated with 2 mM NEM in GPMV buffer for not longer than 2 h. GPMVs from T-cells were prepared using NEM as previously described ([@B34]).

Labeling and immobilization of GPMVs
------------------------------------

The GPMV-containing supernatant was harvested. DSPE-PEG-biotin (Avanti Polar Lipids) was added to a final concentration of 0.2 μg/ml into the GPMV suspension. After 1.5 h, GPMVs were labeled with the ethanol-dissolved lipid analogue Atto647N-DPPE, Atto647N-SM, or Atto647N-DOPE. They were added to the GPMV solution to a final concentration of 0.1, 0.2, and 0.14 μg/ml, respectively. Atto647N-GM1 was dissolved in dimethyl sulfoxide and was added to a final concentration of 4 μg/ml. After another 15 min of incubation, the GPMVs were spun down at 10,000 rpm for 15 min, and the supernatant was replaced by fresh buffer. The last step was crucial for the removal of free biotinylated lipid. For the measurements of GPI-RFP or Lypd6-RFP, an RFP-binding nanobody labeled with Atto647N was added to a final concentration of 2 μg/ml before spinning the GPMVs down.

The GPMVs were immobilized using biotin and streptavidin. Glass coverslips were coated with a 5:1 mixture of BSA/biotinylated BSA (Sigma-Aldrich) for 1.5 h, extensively washed, and incubated with a solution of 200 ng/ml streptavidin (Life Technologies) in PBS. After washing with GPMV buffer, the biotinylated GPMVs were added. Measurements were performed after 20 min. Immobilized GPMVs were stable for several hours.

The formation of GPMVs from other cell lines (CHO or Jurkat) was much faster than for PtK2 (within 2 h). Otherwise, these GPMVs were formed and treated in the same way. The GPMVs were tested for the phase separation before to ensure that they were not phase separated at room temperature. GPMVs from PtK2 cells were found to phase separate below 10°C, and thus they were not phase separated at room temperature (Supplemental Figure S4). Fast-DiO (Sigma Aldrich) and Abberior Star Red-PEG-DSPE were added to GPMV with 100 ng/ml final concentration to label disordered and ordered phases, respectively.

GUVs
----

GUVs were prepared by electroformation ([@B23]). A solution of DOPC (Avanti Polar Lipids) with a concentration of 1 mg/ml in chloroform was spread on platinum wires. After solvent evaporation, the electrodes were dipped into 300 mM sucrose. An electric field with a frequency of 10 Hz and a potential of 2 V was applied for 1 h, followed by a frequency of 2 Hz. GUVs were handled with cut tips and measurements performed in PBS. Coverslips were coated with BSA. GUVs were labeled by adding the lipid analogues TopFluor-Cholesterol (Avanti Polar Lipids), Atto47N-DOPE, Atto647N-SM, or Atto647N-DPPE to a final concentration of 0.05 μg/ml. Atto647N-GM1 was used at a final concentration of 0.005 μg/ml.

Supported lipid bilayers
------------------------

Supported lipid bilayers were prepared by spin coating ([@B10]). The coverslips were previously cleaned and edged by piranha acid (3:1 sulfuric acid and hydrogen peroxide). Coverslips were stored in water for not longer than 1 wk.

A solution of 1 mg/mL DOPC in chloroform/methanol was spin coated onto a coverslip at 3200 rpm for 45 s. The lipid bilayer formed by rehydration with SLB buffer containing 10 mM HEPES and 150 mM NaCl pH 7.4. The SLB was labeled with AbberiorStar Red-DPPE (∼1:2000 M ratio; Abberior) contained in the initial DOPC solution.

Data acquisition and evaluation
-------------------------------

Confocal imaging, confocal FCS, and FCCS measurements were taken on a Zeiss780 LSM inverted confocal microscope equipped with a 40× C-Apochromat NA 1.2 W Corr FCS objective (Zeiss). We used labeled high-density lipoprotein particles (a gift from Herbert Stangl, MedUni Wien, Vienna, Austria) as FCCS positive control and a mixture of Alexa 488 and Alexa 647 as negative control to ensure that the microscope was aligned and full cross-correlation could be obtained. Aside from the control of Atto647N-GM1 in GPMVs (37°C), all measurements were performed at room temperature.

All STED-FCS and STED imaging data were taken on a customized Abberior STED microscope (Abberior Instruments) as previously described ([@B8]; [@B22]). The microscope was equipped with a hardware correlator (Flex02-08D, operated by the manufacturer's software; [Correlator.com](http://Correlator.com)). The dyes were excited using a 640-nm pulsed diode laser (80-MHz repetition rate; PicoQuant) with an average excitation power of 5--10 μW at the objective (UPlanSApo 100×/1.4 oil; Olympus). For STED recordings, fluorescence emission was inhibited using a Mai Tai tunable pulsed laser at 780 nm (80-MHz repetition rate; Newport) with a donut-shaped focal intensity pattern formed by a phase plate within the beam path. The microscope was operated using Abberior's Imspector software.

Using the FoCuS-point fitting software ([@B81]), all FCS data on membrane diffusion in SLBs, GUVs, and GPMVs were fitted to a two-dimensional (2D) diffusion model including triplet-state kinetics (with a fixed relaxation time of 5 μs). For measurements in the plasma membrane of living cells, additional dark-state kinetics (with a fixed relaxation time of 100 μs) for the data of all Atto647N-labeled lipids had to be assumed (as pointed out in [@B46]). The data on free cytoplasmic GFP and Lifeact-GFP were fitted using a three-dimensional diffusion equation with one or two components after determination of the structural parameter by measurements of Alexa 488 in water.

In the STED-FCS measurements, the diameter, *d*, of the observation spot is tuned by the average power *P*~STED~ of the STED laser. We performed STED-FCS measurements of AbberiorStar Red-DPPE in SLBs and GUVs at different *P*~STED~ to accurately calibrate the *d*(*P*~STED~) dependence; more specifically we performed these calibration measurements before every experiments on SLBs (100% DOPC) for the STED-FCS recordings on living cells and on GUVs (100% DOPC) for those on GPMVs. Because AbberiorStar Red-DPPE diffuses freely in both model membranes, we can calculate the *d*(*P*~STED~) dependence using the following equation: and are the transit times of the investigated molecules through the observation spot in confocal and at a certain STED laser power, respectively. The confocal observation spot diameter of *d* = 240 nm was determined from confocal images of 20-nm Crimson beads (Life Technologies) spread out on a poly-[l]{.smallcaps}-lysine (Sigma Aldrich)--coated glass coverslip.

The (apparent) diffusion coefficient, *D*, was calculated from and according to

At least 5--10 different cells were measured for each probe within a single measurement session, resulting in multiple FCS measurements (5--15 s) at different spots across the cell for every STED power. All measurements were repeated at least three times to confirm the reproducibility. Each single set of measurement was carried out in the same region of the cell at different spot sizes (STED laser powers). Power gradient was applied in the reverse order as well to avoid any artifacts due to the increasing laser power (confocal to high STED power and vice versa). Each data point in the graphs show the average of the different days and different cells. Error bars are the SDs of the mean.

Simulations
-----------

We performed Monte Carlo simulations to generate molecular tracks that characterized the different diffusion modes in our investigation. We generated fluorescence traces by passing the generated tracks through Gaussian spots of varying diameter, representative of the effect that different STED powers would have on the detection volume. Simulations were performed in a 2D circular space of radius 2500 nm and iterated using a 0.02-ms time step for a 20-s total duration. One hundred molecules were randomly initiated within the simulation, each with a free diffusion rate of 0.8 µm^2^/s. Molecules that diffused across the simulation boundary were wrapped to the opposite edge of the simulation boundary.

Trap diffusion in the first instance was simulated using a stochastic trapping model in which free diffusion is hindered randomly by molecular complex formation ([@B54]). In this mode, at each time step, we evaluate a probability for switching from the free diffusion state to the hindered state (*D* = 0.1 × 10^−9^ µm^2^/s) and vice versa (in this case, with a probability of *p* = 0.002 in both directions) corresponding to rates *k*~on~ = *k*~off~ = 8 × 10^5^ for binding and release. For the simulation of hop diffusion, we first generated a mesh by randomly dispersing points on a grid and then applying a Voronoi transform on these points. Enough points were added to yield an average Voronoi region size of 100 nm in diameter (diameter calculated as ). Molecules in the hop diffusion simulation that randomly walked into new regions were only allowed to pass into that region based on probability *p*~hop~ = 0.25. If, upon evaluation, the molecule failed *p*~hop~, it would move randomly in its existing region for that time step, whereas otherwise it would transition into the new region.

The spatial domain trapping simulation---an alternative to trapping through molecular complex formation---was performed by distributing circular domains of diameter 20 nm across the simulation area. Enough domains were distributed to cover 50% of the simulation space, and the positions were randomly perturbed over many iterations to ensure that the distribution of domains was random. Furthermore, during the random perturbation process, the domains were prevented from overlapping through a hard constraint. During the simulation, particles that crossed into or out of the domains would only be allowed to do so after evaluation of a probability test with a probability less than the *p*~hop~ value (*p* = 0.002), corresponding to the same rate constant as in the stochastic trapping model. During the simulation, particles that crossed into or out of the domains would only do so if, upon evaluation of a probability, the test was less than the *p*~hop~ value (*p* = 0.002), corresponding to the same rate constant as in the stochastic trapping model. Diffusion inside the circular domains was reduced to *D*~in~ = *D*/3.0, one-third of 0.8 µm^2^/s.

For each simulation, 10 random locations for focal spots were chosen, and in each location, nine different focal spots sizes (40--300 nm) were applied; each simulation was repeated five times, generating 50 replicates for each focal spot size. Intensity traces were correlated using a multiple-tau correlation algorithm ([@B80]) and fitted using the foregoing procedure.
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:   fluorescence correlation spectroscopy

GPI-AP

:   glycophosphatidylinositol-anchored protein
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:   giant plasma membrane vesicle
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:   stimulated emission depletion.
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